Sensitization of cancer cells to DNA damage-induced cell death by specific cell cycle G2 checkpoint abrogation.

No abstract is available for this paper.

• Publication year

  1999

• Venue

  Cancer Research

• Publication date

  1999-12-01

• Fields of study

  Biology, Medicine

• Identifiers
  PMID 10606229
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Cell cycle control and cancer.

  2000cited by this paper
• Nuclear localization of Cdc25 is regulated by DNA damage and a 14-3-3 protein

  1999cited by this paper
• Cell cycle-dependent and ATM-independent expression of human Chk1 kinase

  1999cited by this paper
• Linkage of ATM to cell cycle regulation by the Chk2 protein kinase.

  1998cited by this paper
• Replication checkpoint requires phosphorylation of the phosphatase Cdc25 by Cds1 or Chk1

  1998cited by this paper
• C-TAK1 protein kinase phosphorylates human Cdc25C on serine 216 and promotes 14-3-3 protein binding.

  1998cited by this paper
• Transduction of full-length TAT fusion proteins into mammalian cells: TAT-p27Kip1 induces cell migration

  1998cited by this paper
• Replication checkpoint enforced by kinases Cds1 and Chk1.

  1998cited by this paper
• Mitotic and G2 checkpoint control: regulation of 14-3-3 protein binding by phosphorylation of Cdc25C on serine-216.

  1997cited by this paper
• Conservation of the Chk1 checkpoint pathway in mammals: linkage of DNA damage to Cdk regulation through Cdc25.

  1997cited by this paper
• p53, the Cellular Gatekeeper Review for Growth and Division

  1997cited by this paper
• HOX11 interacts with protein phosphatases PP2A and PP1 and disrupts a G2/M cell-cycle checkpoint

  1997influential reference
• Cdc25 mitotic inducer targeted by chk1 DNA damage checkpoint kinase.

  1997cited by this paper
• Assignment of MARK3 alias KP78 to human chromosome band 14q32.3 by in situ hybridization.

  1997cited by this paper
• Selective radiosensitization of p53–deficient cells by caffeine–mediated activation of p34cdc2 kinase

  1996cited by this paper
• UCN-01: a potent abrogator of G2 checkpoint function in cancer cells with disrupted p53.

  1996cited by this paper
• rad-Dependent Response of the chk1-Encoded Protein Kinase at the DNA Damage Checkpoint

  1996cited by this paper
• A checkpoint regulates the rate of progression through S phase in S. cerevisiae in response to DNA damage.

  1995cited by this paper
• Cell cycle control and cancer.

  1994cited by this paper
• Fission yeast chkl protein kinase links the rad checkpoint pathway to cdc2

  1993cited by this paper
• Caffeine prevents apoptosis and cell cycle effects induced by camptothecin or topotecan in HL-60 cells.

  1993cited by this paper
• The cdc25 protein contains an intrinsic phosphatase activity.

  1991cited by this paper
• Mutation of fission yeast cell cycle control genes abolishes dependence of mitosis on DNA replication.

  1990cited by this paper
• Evaluation of a soluble tetrazolium/formazan assay for cell growth and drug sensitivity in culture using human and other tumor cell lines.

  1988cited by this paper
• Loss of a Mr 78,000 marker in chemically induced transplantable carcinomas and primary carcinoma of human pancreas.

  1988cited by this paper

• Mechanisms of Bisphenols-induced Cervical Cancer: A multidimensional bioinformatics analysis.

  2026cites this paper
• Key signalling pathways in head and neck squamous cell carcinoma: mechanisms and therapeutic targets.

  2025cites this paper
• Synergistic Activity of DNA Damage Response Inhibitors in Combination with Radium-223 in Prostate Cancer

  2024cites this paper
• Targeting Protein Kinase, Membrane-Associated Tyrosine/Threonine 1 (PKMYT1) for Precision Cancer Therapy: From Discovery to Clinical Trial.

  2024cites this paper
• Mutant p53 in head and neck squamous cell carcinoma: Molecular mechanism of gain‑of‑function and targeting therapy (Review)

  2023cites this paper
• Synthesis and Evaluation of Habiterpenol Analogs.

  2022cites this paper
• Carbon Ion Induces Cell Death and G2/M Arrest Through pRb/E2F1Chk2/Cdc2 Signaling Pathway in X-ray Resistant B16F10 Melanoma Cells

  2022cites this paper
• DNA damage response and repair in osteosarcoma: Defects, regulation and therapeutic implications.

  2021cites this paper
• PKMYT1, exacerbating the progression of clear cell renal cell carcinoma, is implied as a biomarker for the diagnosis and prognosis

  2021cites this paper
• Combined Inhibition of Rad51 and Wee1 Enhances Cell Killing in HNSCC Through Induction of Apoptosis Associated With Excessive DNA Damage and Replication Stress

  2021cites this paper
• Overexpression of PKMYT1 Facilitates Tumor Development and Is Correlated with Poor Prognosis in Clear Cell Renal Cell Carcinoma

  2020cites this paper
• Pinostrobin suppresses the Ca2+-Signal-Dependent growth arrest in yeast by inhibiting the Swe1-Mediated G2 Cell-Cycle regulation.

  2020cites this paper
• Computer-aided design, synthesis and biological characterization of novel inhibitors for PKMYT1.

  2019cites this paper
• Application of the SwissDrugDesign Online Resources in Virtual Screening

  2019cites this paper
• Systematic expression analysis of WEE family kinases reveals the importance of PKMYT1 in breast carcinogenesis

  2019cites this paper
• Identification of PKMYT1 inhibitors by screening the GSK published protein kinase inhibitor set I and II.

  2018cites this paper
• Regulation of G 2 / M Transition by Inhibition of WEE 1 and PKMYT 1 Kinases

  2017cites this paper
• 3q26‐29 Amplification in head and neck squamous cell carcinoma: a review of established and prospective oncogenes

  2017cites this paper
• Regulation of G2/M Transition by Inhibition of WEE1 and PKMYT1 Kinases

  2017cites this paper
• ATR inhibition sensitizes cervical cancer cells for platinum-based chemoradiation

  2017cites this paper
• Taurine Protects Mouse Spermatocytes from Ionizing Radiation-Induced Damage Through Activation of Nrf2/HO-1 Signaling

  2017cites this paper
• Isolation and characterization of glycolipids from Synechocystis sp. and its cytotoxic potential against colon cancer

  2017cites this paper
• Synthesis and Antineoplastic Evaluation of Novel Unsymmetrical 1,3,4-Oxadiazoles.

  2016cites this paper
• Genetically-defined novel oral squamous cell carcinoma cell lines for the development of molecular therapies

  2016cites this paper
• Direct interaction of Ikaros and Foxp1 modulates expression of the G protein-coupled receptor G2A in B-lymphocytes and acute lymphoblastic leukemia

  2016cites this paper
• Apoptotic effect of eugenol envolves G2/M phase abrogation accompanied by mitochondrial damage and clastogenic effect on cancer cell in vitro.

  2016cites this paper
• A novel Chk1-binding peptide that enhances genotoxic sensitivity through the cellular redistribution of nuclear Chk1

  2016influential citation
• MicroRNA-191 promotes osteosarcoma cells proliferation by targeting checkpoint kinase 2

  2015cites this paper
• Anti-Colon Cancer Effects of 6-Shogaol Through G2/M Cell Cycle Arrest by p53/p21-cdc2/cdc25A Crosstalk.

  2015cites this paper
• Suppression of Poly(rC)-Binding Protein 4 (PCBP4) reduced cisplatin resistance in human maxillary cancer cells

  2015cites this paper
• Effects of Chk1 inhibitor or paclitaxel on cisplatin-induced cell-cycle kinetics and survival in parental and cisplatin- resistant HeLa cells expressing fluorescent ubiquitination- based cell cycle indicator (Fucci)

  2015cites this paper
• Biological evaluation of 1,3,4-oxadiazoles bis-substitute derivatives as potential anticancer agents

  2014cites this paper
• Different fates of oocytes with DNA double-strand breaks in vitro and in vivo

  2014cites this paper
• Habiterpenol, a novel abrogator of bleomycin-induced G2 arrest in Jurkat cells, produced by Phytohabitans suffuscus 3787_5

  2014cites this paper
• A Fluorescence Anisotropy–Based Myt1 Kinase Binding Assay

  2014cites this paper
• Application of Docking and QM/MM-GBSA Rescoring to Screen for Novel Myt1 Kinase Inhibitors

  2014cites this paper
• Wee-1 Kinase Inhibition Overcomes Cisplatin Resistance Associated with High-Risk TP53 Mutations in Head and Neck Cancer through Mitotic Arrest Followed by Senescence

  2014cites this paper
• Triptolide induced DNA damage in A375.S2 human malignant melanoma cells is mediated via reduction of DNA repair genes.

  2013cites this paper
• Temozolomide-treated Human Glioblastoma Cells p53 Effects Both the Duration of G2/M Arrest and the Fate of

  2013cites this paper
• Inhibiting UHRF1 expression enhances radiosensitivity in human esophageal squamous cell carcinoma

  2013cites this paper
• Evaluation of potential Myt1 kinase inhibitors by TR-FRET based binding assay.

  2013cites this paper
• Chemical genetic screen for inhibitors of human telomerase

  2013cites this paper
• Strategies for targeting the DNA damage response for cancer therapeutics

  2012cites this paper
• In vitro and in silico studies on substrate recognition and acceptance of human PKMYT1, a Cdk1 inhibitory kinase.

  2012cites this paper
• Inhibiting Cell Cycle Kinases in Cancer Therapy

  2012cites this paper
• Interferon-gamma enhances radiation-induced cell death via downregulation of Chk1

  2012cites this paper
• Potentiation of bleomycin in Jurkat cells by fungal pycnidione.

  2012cites this paper
• Radiation resistance due to high expression of miR-21 and G2/M checkpoint arrest in breast cancer cells

  2012cites this paper
• Adeno-associated virus type 2 infection activates caspase dependent and independent apoptosis in multiple breast cancer lines but not in normal mammary epithelial cells

  2011cites this paper
• Screening of a library of T7 phage-displayed peptides identifies alphaC helix in 14-3-3 protein as a CBP501-binding site.

  2011cites this paper
• PRECLINICAL STUDIES ON ATM KINASE INHIBITORS AS ANTI-CANCER AGENTS

  2011cites this paper
• CBS9106 is a novel reversible oral CRM1 inhibitor with CRM1 degrading activity.

  2011cites this paper
• Thioredxin reductase inhibitor ethaselen increases the drug sensitivity of the colon cancer cell line LoVo towards cisplatin via regulation of G1 phase and reversal of G2/M phase arrest

  2011cites this paper
• Growth inhibitory effect and Chk 1-dependent signaling involved in G / M arrest on human gastric cancer cells induced by diallyl 2 disulfide

  2010cites this paper
• Structure‐based quantitative structure‐activity relationship studies of checkpoint kinase 1 inhibitors

  2010cites this paper
• Targeting the checkpoint kinase WEE1: Selective sensitization of cancer cells to DNA-damaging drugs

  2010cites this paper
• Chk1 and Chk2 as Checkpoint Targets

  2010cites this paper
• Cell cycle re-entry mechanisms after DNA damage checkpoints: Giving it some gas to shut off the breaks!

  2010cites this paper
• Growth inhibitory effect and Chk1-dependent signaling involved in G2/M arrest on human gastric cancer cells induced by diallyl disulfide.

  2010cites this paper
• Chapter 16 Chk1 and Chk2 as Checkpoint Targets

  2009cites this paper
• Adeno-Associated Virus Type 2 Induces Apoptosis in Human Papillomavirus-Infected Cell Lines but Not in Normal Keratinocytes

  2009cites this paper
• New combination therapies with cell-cycle agents.

  2008cites this paper
• Synthesis and structure-activity relationships of N-6 substituted analogues of 9-hydroxy-4-phenylpyrrolo[3,4-c]carbazole-1,3(2H,6H)-diones as inhibitors of Wee1 and Chk1 checkpoint kinases.

  2008cites this paper
• Protective mechanisms of p53-p21-pRb proteins against DNA damage-induced cell death

  2008cites this paper
• Synthesis and structure-activity relationships of soluble 8-substituted 4-(2-chlorophenyl)-9-hydroxypyrrolo[3,4-c]carbazole-1,3(2H,6H)-diones as inhibitors of the Wee1 and Chk1 checkpoint kinases.

  2008cites this paper
• Compounds that Abrogate the G2 Checkpoint

  2008cites this paper
• Regulation of Chk1 by its C-terminal domain.

  2008cites this paper
• Cell cycle inhibitors in cancer: current status and future directions

  2008cites this paper
• Molecular docking analysis of the protein–protein interaction between RelA‐associated inhibitor and tumor suppressor protein p53 and its inhibitory effect on p53 action

  2008cites this paper
• Fungal malformins inhibit bleomycin-induced G2 checkpoint in Jurkat cells.

  2007cites this paper
• Cell cycle phenotype-based optimization of G2-abrogating peptides yields CBP501 with a unique mechanism of action at the G2 checkpoint

  2007influential citation
• ATM-NF-kappaB connection as a target for tumor radiosensitization.

  2007cites this paper
• Enhancement of chemotherapeutic efficacy by small molecule inhibition of NF-kappaB and checkpoint kinases.

  2007cites this paper
• p53-Dependent Chk1 Phosphorylation is Required for Maintenance of Prolonged G2 Arrest

  2007cites this paper
• Bis-imide granulatimide analogues as potent Checkpoint 1 kinase inhibitors.

  2007cites this paper
• Targeting cell cycle kinases for cancer therapy.

  2007cites this paper
• High Labeling Indices of cdc25B is Linked to Progression of Gastric Cancers and Associated With a Poor Prognosis

  2007cites this paper
• G2 Checkpoint Kinase Inhibitors Exert Their Radiosensitizing Effects Prior to the G2/M Transition

  2007cites this paper
• Growth inhibition and apoptosis induction in ovarian cancer cells : molecular mechanisms

  2007cites this paper
• ATM-NF-κB Connection as a Target for Tumor Radiosensitization

  2007cites this paper
• Synthesis and biological evaluation of 3-ethylidene-1,3-dihydro-indol-2-ones as novel checkpoint 1 inhibitors.

  2006cites this paper
• Radiosensitization of tumor cells by modulation of ATM kinase

  2006influential citation
• Activated checkpoint kinase 2 provides a survival signal for tumor cells.

  2006cites this paper
• Design and synthesis of diazepine inhibitors as novel anti-cancer agents

  2006cites this paper
• Checkpoint kinase 1‐mediated phosphorylation of Cdc25C and bad proteins are involved in antitumor effects of loratadine‐induced G2/M phase cell‐cycle arrest and apoptosis

  2006cites this paper
• Targeting Hsp90 by 17-AAG in leukemia cells: mechanisms for synergistic and antagonistic drug combinations with arsenic trioxide and Ara-C

  2006cites this paper
• G2 checkpoint abrogation as a cancer specific, cell cycle disruption

  2005cites this paper
• Targeting chk2 kinase: molecular interaction maps and therapeutic rationale.

  2005cites this paper
• Selective inhibition of bleomycin-induced G2 cell cycle checkpoint by simaomicin alpha.

  2004cites this paper
• Boromycin abrogates bleomycin-induced G2 checkpoint.

  2004cites this paper
• Oxaline, a fungal alkaloid, arrests the cell cycle in M phase by inhibition of tubulin polymerization.

  2004influential citation
• G2 checkpoint abrogators as anticancer drugs.

  2004influential citation
• Targeting the cell cycle

  2004cites this paper
• Knockdown of Chk1, Wee1 and Myt1 by RNA Interference Abrogates G2 Checkpoint and Induces Apoptosis

  2004cites this paper
• New monordens produced by amidepsine-producing fungus Humicola sp. FO-2942.

  2003cites this paper
• DNA damage checkpoint control in cells exposed to ionizing radiation

  2003cites this paper
• Human Chk1 expression is dispensable for somatic cell death and critical for sustaining G2 DNA damage checkpoint.

  2003cites this paper
• Synthesis of isogranulatimides A and B analogues possessing a 7-azaindole unit instead of an indole moiety

  2003cites this paper
• Increased cell proliferation is associated with genomic instability: elevated micronuclei frequencies in estradiol-treated human ovarian cancer cells.

  2003cites this paper
• Cdc25C interacts with PCNA at G2/M transition

  2002cites this paper